Yahoo Web Search

  1. Ads
    related to Leukemia
  1. RYE BROOK, N.Y., July 11, 2019 /PRNewswire/ -- A three-way $4.5 million collaboration launched this month between The Leukemia & Lymphoma Society (LLS), The Mark Foundation for Cancer ...

  2. NASDAQ: ARQL) Axsome Therapeutics Inc (NASDAQ: AXSM) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Coherus Biosciences Inc (NASDAQ: CHRS)(announced that it has ...

  3. The Texas billionaire was diagnosed with leukemia in February, the Dallas Morning News reported. “Ross Perot, the ground-breaking businessman and loving husband, brother, father and grandfather ...

  4. H. Ross Perot rose from poverty to self-made billionaire

    Associated Press via Yahoo FinanceJul 09 21:51 PM

    Perot died of leukemia Tuesday at his home in Dallas surrounded by his family, family spokesman James Fuller said. As a boy in Texarkana, Texas, Perot delivered newspapers from the back ...

  5. The self-made billionaire had battled leukemia for months, a family spokesman told The Associated Press. Texas-born Perot, a Naval Academy graduate, started his career as an IBM (NYSE ...

  6. Moleculin, which focuses on drugs targeting highly resistant tumors, said it has filed new patents covering the production and reconstitution of annamycin, its investigational drug for relapsed ...

  7. Moleculin Files New Patents for Cancer Candidate Annamycin

    Zacks via Yahoo FinanceJul 11 15:19 PM

    MBRX announced that it has filed new patents, covering the production and reconstitution of its cancer candidate, annamycin, which is being developed for the treatment of patients with relapsed ...

  8. Ross Perot was Trumpy, years before Trump

    Yahoo FinanceJul 09 14:25 PM

    Twenty-five years before President Donald Trump took office promising to roll back trade deals, H. Ross Perot told a national audience that the “giant sucking sound” voters heard was American ...

  9. Better Buy: Pfizer vs. Johnson & Johnson

    Motley Fool via Yahoo FinanceJul 07 15:17 PM

    If you've taken a look at Pfizer (NYSE: PFE) or Johnson & Johnson (NYSE: JNJ) recently, you've probably noticed both companies have been reporting stagnant revenue growth that doesn't jibe with ...

  10. AVEO Pharmaceuticals Down More Than 50% YTD: Here's Why

    Zacks via Yahoo FinanceJul 08 21:05 PM

    Shares of AVEO Pharmaceuticals, Inc. AVEO have plummeted 57.4% against the industry’s growth of 6.5% in the year so far. AVEO faced a major setback when it had to delay the submission of a new ...

  1. Ads
    related to Leukemia